POCT in coagulation: Quality assurance;Qualitätssicherung bei POCT-methoden in der hämostaseologie

Hamostaseologie

Volumn 30, Issue 2, 2010, Pages 82-90

  Spannagl, Michael ^a,c   Dick, A ^a   Junker, R ^b  

^a Instand Ev   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Labor fur Immungenetik   (Germany)

Author keywords

Coagulation; Platelet function testing; POCT; Quality control; Quality management

Indexed keywords

BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; LABORATORY TEST; POINT OF CARE TESTING; QUALITY CONTROL; REVIEW;

EID: 77952989939     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617043     Document Type: Review

References (31)

1. Avidan MS, Alcock El, Da Fonseca JH et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004; 92: 178-186.
2. Beholz S, Grubitzsch H, Bergmann B et al. Hemostasis management by use of Hepcon/HMS: increased bleeding without increased need for blood transfusion. Thorac Cardiovasc Surg 1999; 47: 322-327.
3. Boldt J, Walz G, Triem J et al. Point-of-care (POC) measurement of coagulation after cardiac surgery. Intensive Care Med 1998; 24: 1187-1193. (Pubitemid 28542934)
4. Bosch YP, Ganushchak YM, de Jong DS. Comparison of ACT point-of-care measurements: repeatability and agreement. Perfusion 2006; 21: 27-31.
5. Calatzis A, Heesen M, Spannagl M. Patientennahe Sofortdiagnostik von Hämostaseveränderungen in der Anästhesie und Intensivmedizin. Anaesthesist 2003; 52: 229-237. (Pubitemid 36437706)
6. Cammerer U, Dietrich W, Rampf T et al. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96: 51-57. (Pubitemid 36042031)
7. Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM. Self-management of oral anticoagulant therapy: A systematic review and meta-analysis. Int J Cardiol 2007; 118: 54-61. (Pubitemid 46517685)
8. Crescente M, Di Castelnuovo A, Iacoviello L et al. PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients. A meta-analysis of 19 studies comprising 3003 patients. Thromb Haemost 2008; 99: 1129-1131.
9. Despotis GJ, Goodnough LT. Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg 2000; 70 (2 Suppl): S20-S32.
10. Ferring M, Reber G, de Moerloose P et al. Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients. Can J Anaesth 2001; 48: 1155-1160. (Pubitemid 34223654)
11. Fressinaud E, Veyradier A, Sigaud M et al. Therapeutic monitoring of the Willebrand disease: interest and limits of platelet function analyzer at high shear rates. Br J Haematol 1999; 106: 777-783. (Pubitemid 29434222)
12. Hartert H. Blutgerinnungstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschrift 1948; 26: 577-583.
13. Hattersley PG.Activated coagulation time of whole blood. JAMA 1966; 196: 436-440.
14. Heneghan C, Alonso-Coello P, Garcia-Alamino JM et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-411. (Pubitemid 43184260)
15. Levi G, Shore-Lesserson L, Harrington D et al. An investigation of a new activated clotting time "MAX-ACT" in patients undergoing extracorporeal circulation. Anesth Analg 2001; 92: 578-583.
16. Luddington RJ. Thromboelastography. Clin Lab Haematol 2005; 27: 81-90.
17. Mc CahonD, Murray ET, Jowett S et al. Patient self management of oral anticoagulation in routine care in the UK. J Clin Pathol 2007; 60: 1263-1267. (Pubitemid 350084549)
18. Murray DJ, Brosnahan WJ, Pennell B et al. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth 1997; 11: 24-28. (Pubitemid 27114203)
19. Rahe-Meyer N, Solomon C, Vorweg M et al. Multicentric comparison of single portion reagents and liquid reagents for thromboelastometry. Blood Coagulation and Fibrinolysis 2009; 20: 218-222.
20. Shore-Lesserson L, Manspeizer HE, DePerio M et al. Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-319. (Pubitemid 29070189)
21. Simon DI, Liu CB, Ganz P et al. A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv 2001; 52: 425-432. (Pubitemid 32275029)
22. Steinhubl SR, Talley JD, Braden GA et al. Point-ofcare measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation 2001; 103: 2572-2578.
23. Theusinger OM, Nürnberg J, Asmis LM et al. Rotation thromboelastometry (ROTEM® stability and reproducibility over time. Eur J Cardiothorac Surg 2009; 37: 677-683.
24. Yuoh C, Tarek Elghetany M, Petersen JR et al. Accuracy and precision of point-of-care testing for glucose and prothrombin time at the critical care units. Clin Chim Acta 2001; 307: 119-123. (Pubitemid 32448913)
25. Zucker ML. The National Academy of Clinical Biochemistry Laboratory Medicine, Practice Guidelines for Point of Care Coagulation Testing. Point of Care 2007; 6: 223-226.
26. Benutzerhandbuch Hemochron Signature Elite, ITC, New Jersey, USA; 2004.
27. Benutzerhandbuch Abbott i-STAT, Illinois, USA; 2005.
28. Benutzerhandbuch Coaguchek XS, Roche Diagnostics, Mannheim.
29. PFA-100® Instruction Manual, Version 1.2, Siemens Healthcare Diagnostics Products GmbH, Eschborn 2009.
30. Multiplate® Handbuch, Dynabyte Informationssysteme GmbH, 2006, München.
31. Bedienerhandbuch ROTEM® delta, Tem International GmbH, München 2010.